Preimplantation genetic diagnosis allows women of childbearing age to select embryos that do not have genetic mutations.
When talking about genetic testing in patients with breast cancer, it is important to frame it as a personal choice that can benefit both the patient and their family, said Kristin Rojas, MD, breast surgical oncologist affiliated with the Brooklyn Breast Program at Maimonides Medical Center.
While more patients and providers are addressing the topic of genetic testing, preimplantation genetic diagnosis for those who are hoping to have children is not talked about as much. Through this process, clinicians can select embryos that do not have the BRCA1 or BRCA2 mutation to be used in reproduction.
Patients With Breast Cancer May Have Increased Risk for Medication-Related Osteonecrosis of the Jaw
August 28th 2024Compared with available literature, the rates of medication-related osteonecrosis of the jaw were higher in patients with breast cancer and bone metastases treated with antiresorptive therapy.
Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium
January 16th 2023Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.